Related Experiment Videos

Organ-associated macrophage precursor cells as effector cells against tumor targets and microorganisms

M L Lohmann-Matthes¹, T Decker, M Baccarini

¹Department of Immunobiology, Fraunhofer Institute of Toxicology and Aerosol Research, Hannover, FRG.

Haematology and Blood Transfusion

|January 1, 1987

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

First-line ET plus palbociclib versus standard mono-chemotherapy in high-risk HR-positive/HER2-negative metastatic breast cancer and indication for chemotherapy: primary results from the randomized phase IV PADMA study.

ESMO open·2026

Unmet need for patients with metastatic triple-negative breast cancer initiating first-line treatment: data from the prospective German tumor registry OPAL.

ESMO real world data and digital oncology·2026

Final results of the INFINITY precision oncology registry: non-standard targeted treatments in patients with advanced cancers in routine care.

ESMO real world data and digital oncology·2026

Risk of disease progression in first-line metastatic colorectal cancer therapy to guide disease reassessments-analysis of 11 trials by AIO and GONO.

Annals of oncology : official journal of the European Society for Medical Oncology·2025

Conditional progression-free survival in patients with metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer treated with first-line ribociclib and endocrine therapy: real-world data from the RIBANNA study.

ESMO open·2025

Impact of primary tumor sidedness and sex on prognosis and anti-epidermal growth factor receptor antibody efficacy in BRAF-mutant metastatic colorectal cancer: a pooled analysis of AIO studies FIRE-1, CIOX, FIRE-3, XELAVIRI, and VOLFI.

ESMO open·2024

See all related articles